INS and cancer: SCD1, which essentially adjusts the cellular ratio of SFAs to MUFAs, improves lipid metabolic profiles and insulin sensitivity24,85–89, maintains skin homeostasis90, and supports tumor growth91,92, metastasis93, cancer stemness94, and chemoresistance95.